Open AccessEffect of Haemophilus influenzae Type b and 13-Valent Pneumococcal Conjugate Vaccines on Childhood Pneumonia Hospitalizations and Deaths in Botswana
Author(s) -
Morgan Congdon,
Hwanhee Hong,
Rebecca Young,
Coleen K. Cunningham,
Leslie A. Enane,
Tonya Arscott-Mills,
Francis Msume Banda,
Mamiki Chise,
Keneilwe Motlhatlhedi,
Kristen A. Feemster,
Sweta Patel,
Sefelani Boiditswe,
Tiroyaone Leburu,
Samir S. Shah,
Andrew P. Steenhoff,
Matthew S. Kelly
Publication year - 2020
Publication title -
clinical infectious diseases/clinical infectious diseases (online. university of chicago. press)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciaa919
Subject(s) - medicine , pneumonia , pneumococcal conjugate vaccine , haemophilus influenzae , pediatrics , vaccination , pneumococcal pneumonia , mortality rate , hib vaccine , conjugate vaccine , streptococcus pneumoniae , immunization , immunology , antibiotics , microbiology and biotechnology , immune system , biology
Globally, pneumonia is the leading cause of death among children. Few data exist regarding the effect of Haemophilus influenzae type b (Hib) vaccine and 13-valent pneumococcal conjugate vaccine (PCV-13) on the burden of childhood pneumonia in African settings.